Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Merrill Starts Alcon at Strong Buy


Merrill Lynch initiated coverage of Alcon (ACL) with a near and long-term strong buy rating.

Analyst Steven Tighe says Alcon is the largest ophthalmic-specific company, a leader in the global eye care market with a 25% share in 2001. He says it is well managed and positioned to generate significant growth. Tighe sees annual top-line growth of 9%, EPS growth in the high-teens to low twenties in the next few years. He cites steady growth of existing products, strong growth of new products, leverage of global infrastructure, strong cash flow and deleveraging and tax rate improvements.

Tighe has a $40 12-month target on the stock, which assumes shares could trade at 25 times his $1.61 2003 EPS estimate.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus